What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2025-03-27 compared with 2024-04-01 · 26 added, 39 removed, 10 unchanged (87% of the section changed)

Market for Registrant’s Common Equity, Related Stockholder

Matters and Issuer Purchases of Equity Securities.

for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of

Equity Securities.

common stock is listed and traded on the NYSE American under the symbol AIM.

1 unchanged sentence

of March 24, 2025, there were approximately 146 holders of record of our Common Stock.

This number was determined from records maintained

by our transfer agent and does not include beneficial owners of our securities whose securities are held in the names of various dealers

and/or clearing agencies.

This number was determined from records

maintained by our transfer agent and does not include beneficial owners of our securities whose securities are held in the names of

various dealers and/or clearing agencies.

Authorized for Issuance Under Equity Compensation Plans

5 unchanged sentences

Sales of Unregistered Securities

Equity Incentive Plan

the year ended December 31, 2022, we issued a total of 850,000 options under the 2018 Equity Incentive Plan, effective September 12,

2018, which will continue in effect for a period of 10 years from its effective date.

the year ended December 31, 2023, we issued a total of 400,000 options under the 2018 Equity Incentive Plan, effective September 12,

2018, which will continue in effect for a period of 10 years from its effective date.

and Directors Purchase Plan

July 7, 2020, the board of directors approved a plan pursuant to which all directors, officers, and employees could purchase from us

up to an aggregate of $500,000 worth of shares at the market price.

Pursuant to NYSE American rules, this plan was effective for a sixty-day

period commencing upon the date that the NYSE American approved our Supplemental Listing Application.

We issued 10,730 shares of our

common stock at a price of $2.33 for a total of $25,000 under this plan.

When this plan expired, the board of directors approved subsequent

similar $500,000 plans for all directors, officers and employees to buy shares from us at the market price.

Subsequent plans were approved

by the board of directors upon the expiration of prior plans.

The last plan approved by the Board of Directors for the fiscal year ended

December 31, 2023, was on October 26, 2023.

the fiscal year ended December 31, 2022, we issued a total of 86,817 shares of our common stock at prices ranging from $0.76 to $1.02

for a total of $80,000 under the plan.

the fiscal year ended December 31, 2023, we issued a total of 419,285 shares of our common stock at prices ranging from $0.31 to $0.67

for a total of $150,500 under the plan.

In March 2024, we sold 204,547

and 38,462 shares of our common stock at prices of $0.33 and $0.39 per share, respectively, under the plan.

December 6, 2023, the Company issued to Azenova, LLC, an option to purchase up to three hundred and sixty thousand (360,000) shares of

our “Common Stock” at a price equal to $0.46 per share.

This Option was awarded pursuant to the Consulting Agreement dated

October 16, 2023 between the Company and Azenova, LLC.

On December 6, 2023, 180,000 options were transferred to Jeffrey Southerton and

180,000 options were transferred to Stacy J.

both transfers with an exercise price of $0.46.

offers, sales and issuances of securities described above was deemed to be exempt from registration under the Securities Act in reliance

on either Section 4(a)(2) in that the issuance of securities to the accredited investors did not involve a public offering, or Rule 701

in that the transactions were under compensatory benefit plans and contracts relating to compensation as provided under Rule 701.

March 15, 2024, Mr.

Equels purchased 75,758 shares of our common stock at a purchase price of $0.33 per share;

Rodino purchased 37,879

shares of our common stock at a purchase price of $0.33 per share;

Appelrouth purchased 90,910 shares of our common stock at

a purchase price of $0.33 per share.

On March 21, 2024, Ms.

Bryan purchased 38,462 shares of our common stock at a purchase price of

On May 6, 2024, Mr.

Equels purchased 61,729 shares of our common stock at a purchase price of $0.405.

On May 6, 2024, Mr.

purchased 30,865 shares of our common stock at a purchase price of $0.405.

One November 20, 2024, Mr.

Equels purchased 60,110 shares

of our common stock at a purchase price of $0,183.

to December 31, 2024, on March 4, 2025, Mr.

Equels purchased 83,334 shares of our common stock at a purchase price of $0.12 price per

purchases were under the Employee Stock Purchase Plan.

No commissions were paid with regard to these sales.

The sales were made pursuant

to the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity